These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38797572)

  • 1. Mucuna pruriens to treat Parkinson's disease in low-income countries: Recommendations and practical guidelines from the farmer to clinical trials. Paving the way for future use in clinical practice.
    Caronni S; Del Sorbo F; Barichella M; Fothergill-Misbah N; Denne T; Laguna J; Urasa S; Dekker MCJ; Akpalu A; Sarfo FS; Cham M; Pezzoli G; Cilia R
    Parkinsonism Relat Disord; 2024 Jul; 124():106983. PubMed ID: 38797572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Could Mucuna pruriens be the answer to Parkinson's disease management in sub-Saharan Africa and other low-income countries worldwide?
    Fothergill-Misbah N; Maroo H; Cham M; Pezzoli G; Walker R; Cilia R
    Parkinsonism Relat Disord; 2020 Apr; 73():3-7. PubMed ID: 32179240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucuna pruriens for Parkinson's disease: Low-cost preparation method, laboratory measures and pharmacokinetics profile.
    Cassani E; Cilia R; Laguna J; Barichella M; Contin M; Cereda E; Isaias IU; Sparvoli F; Akpalu A; Budu KO; Scarpa MT; Pezzoli G
    J Neurol Sci; 2016 Jun; 365():175-80. PubMed ID: 27206902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily intake of Mucuna pruriens in advanced Parkinson's disease: A 16-week, noninferiority, randomized, crossover, pilot study.
    Cilia R; Laguna J; Cassani E; Cereda E; Raspini B; Barichella M; Pezzoli G
    Parkinsonism Relat Disord; 2018 Apr; 49():60-66. PubMed ID: 29352722
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Cilia R; Laguna J; Cassani E; Cereda E; Pozzi NG; Isaias IU; Contin M; Barichella M; Pezzoli G
    Neurology; 2017 Aug; 89(5):432-438. PubMed ID: 28679598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Survey on the Current Advertising and Sales of Mucuna pruriens in Consumer-to-consumer Internet Trading in Japan].
    Sato K; Hida A; Niimi Y; Iwata A; Iwatsubo T
    Yakugaku Zasshi; 2023 Dec; 143(12):1057-1067. PubMed ID: 37839871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study.
    Katzenschlager R; Evans A; Manson A; Patsalos PN; Ratnaraj N; Watt H; Timmermann L; Van der Giessen R; Lees AJ
    J Neurol Neurosurg Psychiatry; 2004 Dec; 75(12):1672-7. PubMed ID: 15548480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the neuroprotective potential of Mucuna pruriens seed extract with estrogen in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice model.
    Yadav SK; Prakash J; Chouhan S; Westfall S; Verma M; Singh TD; Singh SP
    Neurochem Int; 2014 Jan; 65():1-13. PubMed ID: 24333323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Parkinson's disease in Ayurveda: Medicinal plants and adjuvant measures.
    Pathak-Gandhi N; Vaidya AD
    J Ethnopharmacol; 2017 Feb; 197():46-51. PubMed ID: 27544001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antiparkinson drug HP-200 (Mucuna pruriens) on the central monoaminergic neurotransmitters.
    Manyam BV; Dhanasekaran M; Hare TA
    Phytother Res; 2004 Feb; 18(2):97-101. PubMed ID: 15022157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of the antiparkinson drug Mucuna pruriens.
    Manyam BV; Dhanasekaran M; Hare TA
    Phytother Res; 2004 Sep; 18(9):706-12. PubMed ID: 15478206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucuna Pruriens Combined with Carbidopa in Parkinson's Disease: A Case Report.
    Radder DLM; Tiel Groenestege AT; Boers I; Muilwijk EW; Bloem BR
    J Parkinsons Dis; 2019; 9(2):437-439. PubMed ID: 30856121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulation of Parkinson's disease using Mucuna pruriens (Mp).
    Rai SN; Birla H; Zahra W; Singh SS; Singh SP
    J Chem Neuroanat; 2017 Nov; 85():27-35. PubMed ID: 28642128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson's disease.
    Kasture S; Pontis S; Pinna A; Schintu N; Spina L; Longoni R; Simola N; Ballero M; Morelli M
    Neurotox Res; 2009 Feb; 15(2):111-22. PubMed ID: 19384573
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Kamkaen N; Chittasupho C; Vorarat S; Tadtong S; Phrompittayarat W; Okonogi S; Kwankhao P
    Molecules; 2022 May; 27(10):. PubMed ID: 35630617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Levodopa Content in Commercial Mucuna pruriens Products Using High-Performance Liquid Chromatography with Fluorescence Detection.
    Soumyanath A; Denne T; Hiller A; Ramachandran S; Shinto L
    J Altern Complement Med; 2018 Feb; 24(2):182-186. PubMed ID: 28922612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A water extract of Mucuna pruriens provides long-term amelioration of parkinsonism with reduced risk for dyskinesias.
    Lieu CA; Kunselman AR; Manyam BV; Venkiteswaran K; Subramanian T
    Parkinsonism Relat Disord; 2010 Aug; 16(7):458-65. PubMed ID: 20570206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotection by Mucuna pruriens in Neurodegenerative Diseases.
    Zahra W; Birla H; Singh SS; Rathore AS; Dilnashin H; Singh R; Keshri PK; Gautam P; Singh SP
    Neurochem Res; 2022 Jul; 47(7):1816-1829. PubMed ID: 35380400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucuna pruriens in Parkinson Disease: A Kinetic-Dynamic Comparison With Levodopa Standard Formulations.
    Contin M; Lopane G; Passini A; Poli F; Iannello C; Guarino M
    Clin Neuropharmacol; 2015; 38(5):201-3. PubMed ID: 26366963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of soybean ingestion on pharmacokinetics of levodopa and motor symptoms of Parkinson's disease--In relation to the effects of Mucuna pruriens.
    Nagashima Y; Kondo T; Sakata M; Koh J; Ito H
    J Neurol Sci; 2016 Feb; 361():229-34. PubMed ID: 26810548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.